研究表明，早期癌细胞可以通过电子半导体快速检测出来-动脉网

RESEARCH SHOWS EARLY CANCER CELLS CAN BE RAPIDLY DETECTED THROUGH ELECTRONIC SEMICONDUCTORS

CISION 等信源发布 2025-07-15 23:25



可切换为仅中文







CLEVELAND

克利夫兰

，

July 15, 2025

2025年7月15日

/PRNewswire/ -- IdentifySensors Biologics, a leader in digital diagnostic technologies, has demonstrated that its electronic biosensors used to detect pathogens can also detect cancer cells.

/PRNewswire/ -- 数字诊断技术领域的领导者IdentifySensors Biologics已经证明，其用于检测病原体的电子生物传感器还可以检测癌细胞。

As the company advances toward commercialization and regulatory review of its diagnostic platform, Check4, researchers began pursuing new applications for the technology. A major pharmaceutical company provided samples of cancer genes and requested performance testing with the technology.

随着公司朝着其诊断平台Check4的商业化和监管审查迈进，研究人员开始探索该技术的新应用。一家大型制药公司提供了癌症基因样本，并要求使用该技术进行性能测试。

'We have been optimistic that our electronic biosensors could detect cancer, but our research this month supports that theory, at least in preliminary studies and before the FDA reviews the process,' said IdentifySensors CEO

“我们一直乐观地认为我们的电子生物传感器可以检测癌症，但本月的研究至少在初步研究中支持了这一理论，当然还有待FDA审查这一过程，”IdentifySensors首席执行官表示。

Greg Hummer

格雷格·哈默尔

MD. 'As this plays out, the approach could lead to a highly affordable molecular cancer screening test for home use. This could be a major breakthrough in widescale early screening and diagnosis for some of the most predominant forms of the disease.'

MD. “随着这一方法的实施，它可能导致一种用于家庭使用的高性价比分子癌症筛查测试。这可能是在一些最普遍的疾病形式的大规模早期筛查和诊断方面的重大突破。”

Check4 is a gene-detection platform that is built around a reusable portable Bluetooth device and a single-use cartridge that accepts both saliva and blood samples to digitally detect a wide range of diseases, including viral and bacterial infections.

Check4 是一个基因检测平台，围绕可重复使用的便携式蓝牙设备和一次性使用的卡盒构建，该卡盒可接受唾液和血液样本，以数字化方式检测包括病毒和细菌感染在内的多种疾病。

The device connects to the cloud, delivering test results directly to healthcare systems and to patients by email or text message through a mobile app. This platform represents a new class of diagnostics with low-cost electronic circuits on bodily fluids instead of traditional chemical reactions, eliminating the need for lab work, reagents and long wait times..

该设备连接到云端，通过移动应用程序以电子邮件或短信的方式将测试结果直接发送给医疗系统和患者。该平台代表了一类新的诊断技术，使用低成本的电子电路对人体液体进行检测，而非传统的化学反应，从而消除了对实验室工作、试剂和长时间等待的需求。

Inside the device, printed semiconductors produce an electrical signal when a targeted DNA or RNA sequence is detected. These electrical reactions are captured digitally and interpreted by a proprietary cloud-based algorithm. Test results are then transmitted to a healthcare databases or directly to patients for immediate action..

设备内部，当检测到目标DNA或RNA序列时，印刷半导体会产生电信号。这些电反应被数字化捕获，并由专有的基于云的算法进行解读。测试结果随后传输到医疗数据库或直接发送给患者以采取即时行动。

This new technology is protected by 26 issued patents with several more pending. Manufacturing has begun in

这项新技术受到26项已颁发专利的保护，还有几项专利正在申请中。制造已经开始。

the United States

美国

, and the FDA is reviewing a pre-EUA submission for ebolavirus.

，FDA正在审查埃博拉病毒的预EUA提交。

About IdentifySensors Biologics

关于识别传感器生物制品

IdentifySensors Biologics is a nano-biotech company driving a shift in molecular diagnostics from a hardware-heavy, laboratory-based delivery model to a low-cost, portable software-based delivery platform. The advancements leverage new nanomaterials in semiconductors and bioinformatics. For more information visit .

IdentifySensors生物制品是一家纳米生物技术公司，致力于推动分子诊断从依赖硬件、以实验室为基础的交付模式向低成本、便携式、基于软件的交付平台转变。这些进展利用了半导体和生物信息学中的新型纳米材料。欲了解更多信息，请访问。

www.identifysensors.com

识别传感器官网

。

News Media Contact

新闻媒体联系

Joe Mosbrook

乔·莫斯布鲁克

mosbrook@acclaimllc.com

216-375-2141

SOURCE IdentifySensors Biologics

来源：识别传感器生物制品